Enzo Biochem, Inc. (ENZ) Stock Competitors & Peer Comparison
See (ENZ) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ENZ | $0.31 | -6.08% | 16.4M | -2.85 | -$0.11 | +31.87% |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.75% |
| TMO | $494.04 | +0.31% | 183.6B | 27.19 | $18.17 | +0.36% |
| DHR | $179.87 | -1.53% | 127.3B | 34.93 | $5.15 | +0.75% |
| IDXX | $566.79 | +0.58% | 44.7B | 41.74 | $13.58 | N/A |
| A | $136.05 | +0.38% | 38.4B | 27.32 | $4.98 | +0.56% |
| NTRA | $218.81 | -2.04% | 31.3B | -134.08 | -$1.63 | N/A |
| IQV | $186.82 | +2.53% | 31.2B | 23.19 | $8.06 | N/A |
| ILMN | $164.40 | +0.88% | 24.9B | 29.84 | $5.51 | N/A |
| WAT | $378.16 | -1.41% | 24.6B | 48.17 | $7.85 | N/A |
Stock Comparison
ENZ vs DHR-PB Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, ENZ is priced at $0.31, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, ENZ's ROE is -0.10%, compared to DHR-PB's ROE of +0.07%. Regarding short-term risk, ENZ is more volatile compared to DHR-PB. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check DHR-PB's competition here
ENZ vs TMO Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, TMO has a market cap of 183.6B. Regarding current trading prices, ENZ is priced at $0.31, while TMO trades at $494.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas TMO's P/E ratio is 27.19. In terms of profitability, ENZ's ROE is -0.10%, compared to TMO's ROE of +0.13%. Regarding short-term risk, ENZ is more volatile compared to TMO. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check TMO's competition here
ENZ vs DHR Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, DHR has a market cap of 127.3B. Regarding current trading prices, ENZ is priced at $0.31, while DHR trades at $179.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas DHR's P/E ratio is 34.93. In terms of profitability, ENZ's ROE is -0.10%, compared to DHR's ROE of +0.07%. Regarding short-term risk, ENZ is more volatile compared to DHR. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check DHR's competition here
ENZ vs IDXX Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, IDXX has a market cap of 44.7B. Regarding current trading prices, ENZ is priced at $0.31, while IDXX trades at $566.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas IDXX's P/E ratio is 41.74. In terms of profitability, ENZ's ROE is -0.10%, compared to IDXX's ROE of +0.71%. Regarding short-term risk, ENZ is more volatile compared to IDXX. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check IDXX's competition here
ENZ vs A Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, A has a market cap of 38.4B. Regarding current trading prices, ENZ is priced at $0.31, while A trades at $136.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas A's P/E ratio is 27.32. In terms of profitability, ENZ's ROE is -0.10%, compared to A's ROE of +0.21%. Regarding short-term risk, ENZ is more volatile compared to A. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check A's competition here
ENZ vs NTRA Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, NTRA has a market cap of 31.3B. Regarding current trading prices, ENZ is priced at $0.31, while NTRA trades at $218.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas NTRA's P/E ratio is -134.08. In terms of profitability, ENZ's ROE is -0.10%, compared to NTRA's ROE of -0.15%. Regarding short-term risk, ENZ is more volatile compared to NTRA. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check NTRA's competition here
ENZ vs IQV Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, IQV has a market cap of 31.2B. Regarding current trading prices, ENZ is priced at $0.31, while IQV trades at $186.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas IQV's P/E ratio is 23.19. In terms of profitability, ENZ's ROE is -0.10%, compared to IQV's ROE of +0.22%. Regarding short-term risk, ENZ is more volatile compared to IQV. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check IQV's competition here
ENZ vs ILMN Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, ILMN has a market cap of 24.9B. Regarding current trading prices, ENZ is priced at $0.31, while ILMN trades at $164.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas ILMN's P/E ratio is 29.84. In terms of profitability, ENZ's ROE is -0.10%, compared to ILMN's ROE of +0.34%. Regarding short-term risk, ENZ is more volatile compared to ILMN. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check ILMN's competition here
ENZ vs WAT Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, WAT has a market cap of 24.6B. Regarding current trading prices, ENZ is priced at $0.31, while WAT trades at $378.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas WAT's P/E ratio is 48.17. In terms of profitability, ENZ's ROE is -0.10%, compared to WAT's ROE of +0.08%. Regarding short-term risk, ENZ is more volatile compared to WAT. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check WAT's competition here
ENZ vs MTD Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, MTD has a market cap of 23.9B. Regarding current trading prices, ENZ is priced at $0.31, while MTD trades at $1,183.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas MTD's P/E ratio is 27.77. In terms of profitability, ENZ's ROE is -0.10%, compared to MTD's ROE of -6.10%. Regarding short-term risk, ENZ is more volatile compared to MTD. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check MTD's competition here
ENZ vs DGX Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, DGX has a market cap of 21.3B. Regarding current trading prices, ENZ is priced at $0.31, while DGX trades at $192.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas DGX's P/E ratio is 21.26. In terms of profitability, ENZ's ROE is -0.10%, compared to DGX's ROE of +0.14%. Regarding short-term risk, ENZ is more volatile compared to DGX. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check DGX's competition here
ENZ vs LH Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, LH has a market cap of 21.1B. Regarding current trading prices, ENZ is priced at $0.31, while LH trades at $256.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas LH's P/E ratio is 22.75. In terms of profitability, ENZ's ROE is -0.10%, compared to LH's ROE of +0.11%. Regarding short-term risk, ENZ is more volatile compared to LH. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check LH's competition here
ENZ vs EXAS Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, EXAS has a market cap of 20B. Regarding current trading prices, ENZ is priced at $0.31, while EXAS trades at $104.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas EXAS's P/E ratio is -95.37. In terms of profitability, ENZ's ROE is -0.10%, compared to EXAS's ROE of -0.09%. Regarding short-term risk, ENZ is more volatile compared to EXAS. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check EXAS's competition here
ENZ vs GH Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, GH has a market cap of 17.1B. Regarding current trading prices, ENZ is priced at $0.31, while GH trades at $129.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas GH's P/E ratio is -38.09. In terms of profitability, ENZ's ROE is -0.10%, compared to GH's ROE of +1.84%. Regarding short-term risk, ENZ is more volatile compared to GH. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check GH's competition here
ENZ vs PKI Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, ENZ is priced at $0.31, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas PKI's P/E ratio is 41.45. In terms of profitability, ENZ's ROE is -0.10%, compared to PKI's ROE of +0.03%. Regarding short-term risk, ENZ is more volatile compared to PKI. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check PKI's competition here
ENZ vs MEDP Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, MEDP has a market cap of 12.9B. Regarding current trading prices, ENZ is priced at $0.31, while MEDP trades at $451.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas MEDP's P/E ratio is 28.45. In terms of profitability, ENZ's ROE is -0.10%, compared to MEDP's ROE of +1.21%. Regarding short-term risk, ENZ is more volatile compared to MEDP. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check MEDP's competition here
ENZ vs RVTY Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, RVTY has a market cap of 11.2B. Regarding current trading prices, ENZ is priced at $0.31, while RVTY trades at $100.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas RVTY's P/E ratio is 48.33. In terms of profitability, ENZ's ROE is -0.10%, compared to RVTY's ROE of +0.03%. Regarding short-term risk, ENZ is more volatile compared to RVTY. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check RVTY's competition here
ENZ vs ICLR Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, ICLR has a market cap of 10.6B. Regarding current trading prices, ENZ is priced at $0.31, while ICLR trades at $138.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas ICLR's P/E ratio is 47.60. In terms of profitability, ENZ's ROE is -0.10%, compared to ICLR's ROE of +0.02%. Regarding short-term risk, ENZ is more volatile compared to ICLR. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check ICLR's competition here
ENZ vs CRL Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, CRL has a market cap of 8.8B. Regarding current trading prices, ENZ is priced at $0.31, while CRL trades at $182.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas CRL's P/E ratio is -49.24. In terms of profitability, ENZ's ROE is -0.10%, compared to CRL's ROE of -0.06%. Regarding short-term risk, ENZ is more volatile compared to CRL. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check CRL's competition here
ENZ vs QGEN Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, QGEN has a market cap of 7.5B. Regarding current trading prices, ENZ is priced at $0.31, while QGEN trades at $36.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas QGEN's P/E ratio is 18.46. In terms of profitability, ENZ's ROE is -0.10%, compared to QGEN's ROE of +0.11%. Regarding short-term risk, ENZ is more volatile compared to QGEN. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check QGEN's competition here
ENZ vs SYNH Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, ENZ is priced at $0.31, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas SYNH's P/E ratio is 61.40. In terms of profitability, ENZ's ROE is -0.10%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, ENZ is more volatile compared to SYNH. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check SYNH's competition here
ENZ vs SHC Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, SHC has a market cap of 4.4B. Regarding current trading prices, ENZ is priced at $0.31, while SHC trades at $15.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas SHC's P/E ratio is 37.90. In terms of profitability, ENZ's ROE is -0.10%, compared to SHC's ROE of +0.21%. Regarding short-term risk, ENZ is more volatile compared to SHC. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check SHC's competition here
ENZ vs TWST Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, TWST has a market cap of 4.2B. Regarding current trading prices, ENZ is priced at $0.31, while TWST trades at $67.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas TWST's P/E ratio is -51.41. In terms of profitability, ENZ's ROE is -0.10%, compared to TWST's ROE of -0.17%. Regarding short-term risk, ENZ is more volatile compared to TWST. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check TWST's competition here
ENZ vs BLLN Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, BLLN has a market cap of 4.2B. Regarding current trading prices, ENZ is priced at $0.31, while BLLN trades at $91.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas BLLN's P/E ratio is 168.74. In terms of profitability, ENZ's ROE is -0.10%, compared to BLLN's ROE of +0.08%. Regarding short-term risk, ENZ is more volatile compared to BLLN. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check BLLN's competition here
ENZ vs RDNT Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, RDNT has a market cap of 4.2B. Regarding current trading prices, ENZ is priced at $0.31, while RDNT trades at $52.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas RDNT's P/E ratio is -311.12. In terms of profitability, ENZ's ROE is -0.10%, compared to RDNT's ROE of -0.01%. Regarding short-term risk, ENZ is more volatile compared to RDNT. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check RDNT's competition here
ENZ vs OLK Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, ENZ is priced at $0.31, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas OLK's P/E ratio is -96.59. In terms of profitability, ENZ's ROE is -0.10%, compared to OLK's ROE of -0.07%. Regarding short-term risk, ENZ is more volatile compared to OLK. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check OLK's competition here
ENZ vs GRAL Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, GRAL has a market cap of 2.8B. Regarding current trading prices, ENZ is priced at $0.31, while GRAL trades at $64.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas GRAL's P/E ratio is -6.25. In terms of profitability, ENZ's ROE is -0.10%, compared to GRAL's ROE of -0.16%. Regarding short-term risk, ENZ is more volatile compared to GRAL. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check GRAL's competition here
ENZ vs NEOG Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, NEOG has a market cap of 1.9B. Regarding current trading prices, ENZ is priced at $0.31, while NEOG trades at $8.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas NEOG's P/E ratio is -3.19. In terms of profitability, ENZ's ROE is -0.10%, compared to NEOG's ROE of -0.29%. Regarding short-term risk, ENZ is more volatile compared to NEOG. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check NEOG's competition here
ENZ vs CDNA Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, CDNA has a market cap of 1.2B. Regarding current trading prices, ENZ is priced at $0.31, while CDNA trades at $22.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas CDNA's P/E ratio is -142.50. In terms of profitability, ENZ's ROE is -0.10%, compared to CDNA's ROE of -0.03%. Regarding short-term risk, ENZ is more volatile compared to CDNA. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check CDNA's competition here
ENZ vs PSNL Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, PSNL has a market cap of 999.9M. Regarding current trading prices, ENZ is priced at $0.31, while PSNL trades at $11.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas PSNL's P/E ratio is -11.04. In terms of profitability, ENZ's ROE is -0.10%, compared to PSNL's ROE of -0.44%. Regarding short-term risk, ENZ is more volatile compared to PSNL. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check PSNL's competition here
ENZ vs CSTL Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, CSTL has a market cap of 636M. Regarding current trading prices, ENZ is priced at $0.31, while CSTL trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas CSTL's P/E ratio is -49.93. In terms of profitability, ENZ's ROE is -0.10%, compared to CSTL's ROE of -0.03%. Regarding short-term risk, ENZ is more volatile compared to CSTL. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check CSTL's competition here
ENZ vs GRALV Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, ENZ is priced at $0.31, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas GRALV's P/E ratio is N/A. In terms of profitability, ENZ's ROE is -0.10%, compared to GRALV's ROE of N/A. Regarding short-term risk, ENZ is more volatile compared to GRALV. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check GRALV's competition here
ENZ vs FLGT Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, FLGT has a market cap of 513.8M. Regarding current trading prices, ENZ is priced at $0.31, while FLGT trades at $18.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas FLGT's P/E ratio is -7.54. In terms of profitability, ENZ's ROE is -0.10%, compared to FLGT's ROE of -0.07%. Regarding short-term risk, ENZ is more volatile compared to FLGT. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check FLGT's competition here
ENZ vs MYGN Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, MYGN has a market cap of 404.2M. Regarding current trading prices, ENZ is priced at $0.31, while MYGN trades at $4.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas MYGN's P/E ratio is -0.99. In terms of profitability, ENZ's ROE is -0.10%, compared to MYGN's ROE of -1.09%. Regarding short-term risk, ENZ is more volatile compared to MYGN. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check MYGN's competition here
ENZ vs CO Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, ENZ is priced at $0.31, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas CO's P/E ratio is 5.06. In terms of profitability, ENZ's ROE is -0.10%, compared to CO's ROE of +0.11%. Regarding short-term risk, ENZ is less volatile compared to CO. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.Check CO's competition here
ENZ vs PRE Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, PRE has a market cap of 346.6M. Regarding current trading prices, ENZ is priced at $0.31, while PRE trades at $20.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas PRE's P/E ratio is -8.29. In terms of profitability, ENZ's ROE is -0.10%, compared to PRE's ROE of -0.36%. Regarding short-term risk, ENZ is more volatile compared to PRE. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check PRE's competition here
ENZ vs FLDM Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, ENZ is priced at $0.31, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas FLDM's P/E ratio is -4.74. In terms of profitability, ENZ's ROE is -0.10%, compared to FLDM's ROE of +0.17%. Regarding short-term risk, ENZ is more volatile compared to FLDM. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check FLDM's competition here
ENZ vs NEO Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, NEO has a market cap of 271.9M. Regarding current trading prices, ENZ is priced at $0.31, while NEO trades at $10.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas NEO's P/E ratio is -13.56. In terms of profitability, ENZ's ROE is -0.10%, compared to NEO's ROE of -0.12%. Regarding short-term risk, ENZ is more volatile compared to NEO. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check NEO's competition here
ENZ vs OPGN Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, OPGN has a market cap of 242.7M. Regarding current trading prices, ENZ is priced at $0.31, while OPGN trades at $23.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas OPGN's P/E ratio is 132.83. In terms of profitability, ENZ's ROE is -0.10%, compared to OPGN's ROE of +1.58%. Regarding short-term risk, ENZ is more volatile compared to OPGN. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check OPGN's competition here
ENZ vs IMDX Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, IMDX has a market cap of 165.3M. Regarding current trading prices, ENZ is priced at $0.31, while IMDX trades at $6.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas IMDX's P/E ratio is -4.08. In terms of profitability, ENZ's ROE is -0.10%, compared to IMDX's ROE of +3.81%. Regarding short-term risk, ENZ is more volatile compared to IMDX. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check IMDX's competition here
ENZ vs XGN Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, XGN has a market cap of 129.3M. Regarding current trading prices, ENZ is priced at $0.31, while XGN trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas XGN's P/E ratio is -5.94. In terms of profitability, ENZ's ROE is -0.10%, compared to XGN's ROE of -1.14%. Regarding short-term risk, ENZ is more volatile compared to XGN. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check XGN's competition here
ENZ vs GTH Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, ENZ is priced at $0.31, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas GTH's P/E ratio is -1.11. In terms of profitability, ENZ's ROE is -0.10%, compared to GTH's ROE of -1.01%. Regarding short-term risk, ENZ is more volatile compared to GTH. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check GTH's competition here
ENZ vs BDSX Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, BDSX has a market cap of 124.3M. Regarding current trading prices, ENZ is priced at $0.31, while BDSX trades at $15.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas BDSX's P/E ratio is -3.86. In terms of profitability, ENZ's ROE is -0.10%, compared to BDSX's ROE of -21.01%. Regarding short-term risk, ENZ is more volatile compared to BDSX. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check BDSX's competition here
ENZ vs STIM Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, STIM has a market cap of 116.2M. Regarding current trading prices, ENZ is priced at $0.31, while STIM trades at $1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas STIM's P/E ratio is -3.09. In terms of profitability, ENZ's ROE is -0.10%, compared to STIM's ROE of -1.65%. Regarding short-term risk, ENZ is more volatile compared to STIM. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check STIM's competition here
ENZ vs ATLN Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, ATLN has a market cap of 115.9M. Regarding current trading prices, ENZ is priced at $0.31, while ATLN trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas ATLN's P/E ratio is -1.35. In terms of profitability, ENZ's ROE is -0.10%, compared to ATLN's ROE of +2.74%. Regarding short-term risk, ENZ is more volatile compared to ATLN. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check ATLN's competition here
ENZ vs GENE Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, ENZ is priced at $0.31, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas GENE's P/E ratio is -38.25. In terms of profitability, ENZ's ROE is -0.10%, compared to GENE's ROE of -1.85%. Regarding short-term risk, ENZ is more volatile compared to GENE. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check GENE's competition here
ENZ vs SERA Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, SERA has a market cap of 83.6M. Regarding current trading prices, ENZ is priced at $0.31, while SERA trades at $2.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas SERA's P/E ratio is -3.42. In terms of profitability, ENZ's ROE is -0.10%, compared to SERA's ROE of -0.41%. Regarding short-term risk, ENZ is more volatile compared to SERA. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check SERA's competition here
ENZ vs DRIO Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, DRIO has a market cap of 56.3M. Regarding current trading prices, ENZ is priced at $0.31, while DRIO trades at $7.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas DRIO's P/E ratio is -0.91. In terms of profitability, ENZ's ROE is -0.10%, compared to DRIO's ROE of +0.93%. Regarding short-term risk, ENZ is more volatile compared to DRIO. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check DRIO's competition here
ENZ vs STRR Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, STRR has a market cap of 43.3M. Regarding current trading prices, ENZ is priced at $0.31, while STRR trades at $11.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas STRR's P/E ratio is -4.68. In terms of profitability, ENZ's ROE is -0.10%, compared to STRR's ROE of -0.14%. Regarding short-term risk, ENZ is more volatile compared to STRR. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check STRR's competition here
ENZ vs PRPO Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, PRPO has a market cap of 40.3M. Regarding current trading prices, ENZ is priced at $0.31, while PRPO trades at $22.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas PRPO's P/E ratio is -50.07. In terms of profitability, ENZ's ROE is -0.10%, compared to PRPO's ROE of -0.07%. Regarding short-term risk, ENZ is more volatile compared to PRPO. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check PRPO's competition here
ENZ vs MDXH Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, MDXH has a market cap of 33.9M. Regarding current trading prices, ENZ is priced at $0.31, while MDXH trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas MDXH's P/E ratio is -1.02. In terms of profitability, ENZ's ROE is -0.10%, compared to MDXH's ROE of +4.03%. Regarding short-term risk, ENZ is less volatile compared to MDXH. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.Check MDXH's competition here
ENZ vs STRRP Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, STRRP has a market cap of 33.2M. Regarding current trading prices, ENZ is priced at $0.31, while STRRP trades at $9.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas STRRP's P/E ratio is -4.91. In terms of profitability, ENZ's ROE is -0.10%, compared to STRRP's ROE of -0.14%. Regarding short-term risk, ENZ is more volatile compared to STRRP. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check STRRP's competition here
ENZ vs QUCY Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, QUCY has a market cap of 27.9M. Regarding current trading prices, ENZ is priced at $0.31, while QUCY trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas QUCY's P/E ratio is -0.10. In terms of profitability, ENZ's ROE is -0.10%, compared to QUCY's ROE of -2.44%. Regarding short-term risk, ENZ is more volatile compared to QUCY. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check QUCY's competition here
ENZ vs AKU Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, ENZ is priced at $0.31, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas AKU's P/E ratio is -0.13. In terms of profitability, ENZ's ROE is -0.10%, compared to AKU's ROE of -5.32%. Regarding short-term risk, ENZ is more volatile compared to AKU. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check AKU's competition here
ENZ vs CEMI Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, ENZ is priced at $0.31, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas CEMI's P/E ratio is -0.63. In terms of profitability, ENZ's ROE is -0.10%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, ENZ is more volatile compared to CEMI. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check CEMI's competition here
ENZ vs PMD Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, PMD has a market cap of 15.6M. Regarding current trading prices, ENZ is priced at $0.31, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas PMD's P/E ratio is -5.24. In terms of profitability, ENZ's ROE is -0.10%, compared to PMD's ROE of -0.32%. Regarding short-term risk, ENZ is more volatile compared to PMD. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check PMD's competition here
ENZ vs ME Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, ME has a market cap of 15.3M. Regarding current trading prices, ENZ is priced at $0.31, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas ME's P/E ratio is -0.03. In terms of profitability, ENZ's ROE is -0.10%, compared to ME's ROE of -7.71%. Regarding short-term risk, ENZ is more volatile compared to ME. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check ME's competition here
ENZ vs MYNZ Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, MYNZ has a market cap of 14.7M. Regarding current trading prices, ENZ is priced at $0.31, while MYNZ trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas MYNZ's P/E ratio is -0.68. In terms of profitability, ENZ's ROE is -0.10%, compared to MYNZ's ROE of -10.25%. Regarding short-term risk, ENZ is more volatile compared to MYNZ. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check MYNZ's competition here
ENZ vs VNRX Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, VNRX has a market cap of 14.1M. Regarding current trading prices, ENZ is priced at $0.31, while VNRX trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas VNRX's P/E ratio is -0.62. In terms of profitability, ENZ's ROE is -0.10%, compared to VNRX's ROE of +0.74%. Regarding short-term risk, ENZ is more volatile compared to VNRX. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check VNRX's competition here
ENZ vs CHEK Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, CHEK has a market cap of 10.9M. Regarding current trading prices, ENZ is priced at $0.31, while CHEK trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas CHEK's P/E ratio is -0.43. In terms of profitability, ENZ's ROE is -0.10%, compared to CHEK's ROE of -2.26%. Regarding short-term risk, ENZ is more volatile compared to CHEK. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check CHEK's competition here
ENZ vs NOTV Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, NOTV has a market cap of 10.7M. Regarding current trading prices, ENZ is priced at $0.31, while NOTV trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas NOTV's P/E ratio is -0.12. In terms of profitability, ENZ's ROE is -0.10%, compared to NOTV's ROE of -0.75%. Regarding short-term risk, ENZ is more volatile compared to NOTV. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check NOTV's competition here
ENZ vs MBAI Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, MBAI has a market cap of 10.2M. Regarding current trading prices, ENZ is priced at $0.31, while MBAI trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas MBAI's P/E ratio is 2.64. In terms of profitability, ENZ's ROE is -0.10%, compared to MBAI's ROE of +4.17%. Regarding short-term risk, ENZ is more volatile compared to MBAI. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check MBAI's competition here
ENZ vs CNTG Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, ENZ is priced at $0.31, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas CNTG's P/E ratio is -0.23. In terms of profitability, ENZ's ROE is -0.10%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, ENZ is more volatile compared to CNTG. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check CNTG's competition here
ENZ vs BNR Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, BNR has a market cap of 9.3M. Regarding current trading prices, ENZ is priced at $0.31, while BNR trades at $8.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas BNR's P/E ratio is -11.38. In terms of profitability, ENZ's ROE is -0.10%, compared to BNR's ROE of -0.10%. Regarding short-term risk, ENZ is more volatile compared to BNR. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check BNR's competition here
ENZ vs BIAF Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, BIAF has a market cap of 7.9M. Regarding current trading prices, ENZ is priced at $0.31, while BIAF trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas BIAF's P/E ratio is -0.37. In terms of profitability, ENZ's ROE is -0.10%, compared to BIAF's ROE of -3.59%. Regarding short-term risk, ENZ is more volatile compared to BIAF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check BIAF's competition here
ENZ vs TRIB Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, TRIB has a market cap of 7.3M. Regarding current trading prices, ENZ is priced at $0.31, while TRIB trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas TRIB's P/E ratio is -0.35. In terms of profitability, ENZ's ROE is -0.10%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, ENZ is more volatile compared to TRIB. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check TRIB's competition here
ENZ vs APDN Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, APDN has a market cap of 7.3M. Regarding current trading prices, ENZ is priced at $0.31, while APDN trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas APDN's P/E ratio is -0.10. In terms of profitability, ENZ's ROE is -0.10%, compared to APDN's ROE of -6.53%. Regarding short-term risk, ENZ is more volatile compared to APDN. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check APDN's competition here
ENZ vs NVTA Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, ENZ is priced at $0.31, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas NVTA's P/E ratio is -0.00. In terms of profitability, ENZ's ROE is -0.10%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, ENZ is less volatile compared to NVTA. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.Check NVTA's competition here
ENZ vs LMDXW Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, ENZ is priced at $0.31, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, ENZ's ROE is -0.10%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, ENZ is less volatile compared to LMDXW. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.Check LMDXW's competition here
ENZ vs LMDX Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, ENZ is priced at $0.31, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas LMDX's P/E ratio is -0.01. In terms of profitability, ENZ's ROE is -0.10%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, ENZ is less volatile compared to LMDX. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.Check LMDX's competition here
ENZ vs ADVB Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, ADVB has a market cap of 4.7M. Regarding current trading prices, ENZ is priced at $0.31, while ADVB trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas ADVB's P/E ratio is 1.09. In terms of profitability, ENZ's ROE is -0.10%, compared to ADVB's ROE of -0.20%. Regarding short-term risk, ENZ is more volatile compared to ADVB. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check ADVB's competition here
ENZ vs BGLC Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, BGLC has a market cap of 4.5M. Regarding current trading prices, ENZ is priced at $0.31, while BGLC trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas BGLC's P/E ratio is -1.50. In terms of profitability, ENZ's ROE is -0.10%, compared to BGLC's ROE of -0.37%. Regarding short-term risk, ENZ is more volatile compared to BGLC. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check BGLC's competition here
ENZ vs NDRA Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, NDRA has a market cap of 4.2M. Regarding current trading prices, ENZ is priced at $0.31, while NDRA trades at $5.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas NDRA's P/E ratio is -0.69. In terms of profitability, ENZ's ROE is -0.10%, compared to NDRA's ROE of -5.13%. Regarding short-term risk, ENZ is more volatile compared to NDRA. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check NDRA's competition here
ENZ vs BNGO Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, BNGO has a market cap of 4.1M. Regarding current trading prices, ENZ is priced at $0.31, while BNGO trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas BNGO's P/E ratio is -0.28. In terms of profitability, ENZ's ROE is -0.10%, compared to BNGO's ROE of -0.71%. Regarding short-term risk, ENZ is more volatile compared to BNGO. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check BNGO's competition here
ENZ vs DMTK Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, ENZ is priced at $0.31, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas DMTK's P/E ratio is -0.04. In terms of profitability, ENZ's ROE is -0.10%, compared to DMTK's ROE of -1.06%. Regarding short-term risk, ENZ is more volatile compared to DMTK. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check DMTK's competition here
ENZ vs SQL Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, ENZ is priced at $0.31, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas SQL's P/E ratio is -0.40. In terms of profitability, ENZ's ROE is -0.10%, compared to SQL's ROE of +2.74%. Regarding short-term risk, ENZ is more volatile compared to SQL. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check SQL's competition here
ENZ vs AWH Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, AWH has a market cap of 2.5M. Regarding current trading prices, ENZ is priced at $0.31, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas AWH's P/E ratio is -0.09. In terms of profitability, ENZ's ROE is -0.10%, compared to AWH's ROE of +2.03%. Regarding short-term risk, ENZ is more volatile compared to AWH. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check AWH's competition here
ENZ vs INBS Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, INBS has a market cap of 1.6M. Regarding current trading prices, ENZ is priced at $0.31, while INBS trades at $2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas INBS's P/E ratio is -0.21. In terms of profitability, ENZ's ROE is -0.10%, compared to INBS's ROE of -1.74%. Regarding short-term risk, ENZ is more volatile compared to INBS. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check INBS's competition here
ENZ vs HTGM Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, ENZ is priced at $0.31, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas HTGM's P/E ratio is -0.03. In terms of profitability, ENZ's ROE is -0.10%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, ENZ is more volatile compared to HTGM. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check HTGM's competition here
ENZ vs BIAFW Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, BIAFW has a market cap of 899.4K. Regarding current trading prices, ENZ is priced at $0.31, while BIAFW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas BIAFW's P/E ratio is N/A. In terms of profitability, ENZ's ROE is -0.10%, compared to BIAFW's ROE of -3.59%. Regarding short-term risk, ENZ is less volatile compared to BIAFW. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.Check BIAFW's competition here
ENZ vs ISPC Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, ISPC has a market cap of 463.8K. Regarding current trading prices, ENZ is priced at $0.31, while ISPC trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas ISPC's P/E ratio is -0.01. In terms of profitability, ENZ's ROE is -0.10%, compared to ISPC's ROE of -5.85%. Regarding short-term risk, ENZ is more volatile compared to ISPC. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check ISPC's competition here
ENZ vs BIOC Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, ENZ is priced at $0.31, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas BIOC's P/E ratio is -0.01. In terms of profitability, ENZ's ROE is -0.10%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, ENZ is more volatile compared to BIOC. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check BIOC's competition here
ENZ vs PRENW Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, PRENW has a market cap of 202.3K. Regarding current trading prices, ENZ is priced at $0.31, while PRENW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas PRENW's P/E ratio is N/A. In terms of profitability, ENZ's ROE is -0.10%, compared to PRENW's ROE of -0.36%. Regarding short-term risk, ENZ is less volatile compared to PRENW. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.Check PRENW's competition here
ENZ vs SQLLW Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, SQLLW has a market cap of 164.5K. Regarding current trading prices, ENZ is priced at $0.31, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas SQLLW's P/E ratio is -0.01. In terms of profitability, ENZ's ROE is -0.10%, compared to SQLLW's ROE of +2.74%. Regarding short-term risk, ENZ is less volatile compared to SQLLW. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.Check SQLLW's competition here
ENZ vs TTOO Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, TTOO has a market cap of 56.1K. Regarding current trading prices, ENZ is priced at $0.31, while TTOO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas TTOO's P/E ratio is -0.07. In terms of profitability, ENZ's ROE is -0.10%, compared to TTOO's ROE of +1.47%. Regarding short-term risk, ENZ is more volatile compared to TTOO. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check TTOO's competition here
ENZ vs CHEKZ Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, CHEKZ has a market cap of 0. Regarding current trading prices, ENZ is priced at $0.31, while CHEKZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas CHEKZ's P/E ratio is N/A. In terms of profitability, ENZ's ROE is -0.10%, compared to CHEKZ's ROE of +4.17%. Regarding short-term risk, ENZ is less volatile compared to CHEKZ. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.Check CHEKZ's competition here
ENZ vs BNGOW Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, BNGOW has a market cap of 0. Regarding current trading prices, ENZ is priced at $0.31, while BNGOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas BNGOW's P/E ratio is N/A. In terms of profitability, ENZ's ROE is -0.10%, compared to BNGOW's ROE of -0.71%. Regarding short-term risk, ENZ is less volatile compared to BNGOW. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.Check BNGOW's competition here
ENZ vs NDRAW Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, NDRAW has a market cap of 0. Regarding current trading prices, ENZ is priced at $0.31, while NDRAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas NDRAW's P/E ratio is N/A. In terms of profitability, ENZ's ROE is -0.10%, compared to NDRAW's ROE of -5.13%. Regarding short-term risk, ENZ is less volatile compared to NDRAW. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.Check NDRAW's competition here
ENZ vs MEUSW Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, ENZ is priced at $0.31, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas MEUSW's P/E ratio is N/A. In terms of profitability, ENZ's ROE is -0.10%, compared to MEUSW's ROE of -7.71%. Regarding short-term risk, ENZ is less volatile compared to MEUSW. This indicates potentially lower risk in terms of short-term price fluctuations for ENZ.Check MEUSW's competition here
ENZ vs OCDX Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, OCDX has a market cap of 0. Regarding current trading prices, ENZ is priced at $0.31, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas OCDX's P/E ratio is -42.28. In terms of profitability, ENZ's ROE is -0.10%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, ENZ is more volatile compared to OCDX. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check OCDX's competition here
ENZ vs PRXL Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, PRXL has a market cap of 0. Regarding current trading prices, ENZ is priced at $0.31, while PRXL trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas PRXL's P/E ratio is N/A. In terms of profitability, ENZ's ROE is -0.10%, compared to PRXL's ROE of +0.17%. Regarding short-term risk, ENZ is more volatile compared to PRXL. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check PRXL's competition here
ENZ vs DHR-PA Comparison June 2026
ENZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZ stands at 16.4M. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, ENZ is priced at $0.31, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZ currently has a P/E ratio of -2.85, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, ENZ's ROE is -0.10%, compared to DHR-PA's ROE of +0.07%. Regarding short-term risk, ENZ is more volatile compared to DHR-PA. This indicates potentially higher risk in terms of short-term price fluctuations for ENZ.Check DHR-PA's competition here